Mice have proven to be extremely useful tools for simulating pathways involved in humoral autoimmune diseases observed in patients. A relevant animal model can act as a means with which existing drugs can be tested, and new ones rationally designed. With a view to rationally developing animal models, the common features of organ-specific autoantibody-mediated diseases are briefly recalled herein. Historically however, hurdles have often existed that have thwarted the description of these features,, and therefore the development, and testing of hypotheses that explain pathways that yield autoimmune pathologies. The difficulties in assembling these hypotheses from human data have included acquisition of sufficient information regarding antibodies, antigens, and genetics,, and the subsequent marrying of these data-sets with particular clinical manifestations. Moreover, once well-assembled hypotheses have been generated, appropriate platforms for their testing are frequently absent. In the mouse, the immunologists' 'go-to' simulation platform, components integral to mounting antigen specific immune responses are often poorly conserved, or even absent. In this review, following a description of some of the cross species inconsistencies, tools such as plasmids for expressing murine monoclonal antibodies with human variable regions,, and mice engineered to express human Fcγ receptors,, and HLA molecules, often capable of surmounting these issues, are highlighted. By avoiding historical pitfalls,, and considering how new technologies could be employed in the future, a rational approach will be devised for the detailed characterization of the recently discovered organ-specific autoimmune phenomenon of lupus tubulointerstitial nephritis (TIN),, and an animal model that simulates it.
Humoral Autoimmunity: The Conventional ModelIrrespective of the order in which their distinguishing characteristics have been identified, most T cell dependent, antibody-mediated autoimmune diseases end up adhering to the same (admittedly oversimplified) conventional model; in individuals, genetically predisposed to being less immunologically tolerant, who are exposed to particular environmental factors (not discussed in this article),, and with the capacity to present autoantigens because of carriage of particular HLA alleles, autoimmunity to particular autoantigens ensues (Wegner et al. [1]). Providing sufficient accumulation of target autoantigens, the autoantibodies that develop (often measurable in the serum) perpetuate chronic inflammation in particular tissues. Characterization of autoimmune phenomena in patients often results in the development of clinically useful serological assays for diagnosing particular diseases,, and hypotheses regarding pathogenic pathways. However, it is the development of animal models that many researchers often strive most vehemently towards. This is because they not only serve to test our hypotheses regarding disease pathways, they may also be useful as in vivo systems, with which drugs can be tes...